The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy.
about
Treatment in canine epilepsy--a systematic reviewThe use of imepitoin (Pexion™) on fear and anxiety related problems in dogs - a case series.Imepitoin is well tolerated in healthy and epileptic cats.Investigating the potential of the anti-epileptic drug imepitoin as a treatment for co-morbid anxiety in dogs with idiopathic epilepsyImepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs.International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsyInternational Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in EuropeEfficacy, safety, and tolerability of imepitoin in dogs with newly diagnosed epilepsy in a randomized controlled clinical study with long-term follow up.Clinical evaluation of a combination therapy of imepitoin with phenobarbital in dogs with refractory idiopathic epilepsy.Canine epilepsy: an underutilized model.Disease modification in epilepsy: from animal models to clinical applications.Clonazepam in the treatment of status epilepticus.2015 ACVIM Small Animal Consensus Statement on Seizure Management in Dogs.Computational approaches for innovative antiepileptic drug discovery.Comparing the effects of first-line antiepileptic drugs on the gait of dogs with idiopathic epilepsy.Imepitoin Shows Benzodiazepine-Like Effects in Models of Anxiety
P2860
Q27012923-D51E272C-7D50-4FFD-9878-87EDE9D743F3Q30855710-C3896F53-CC0A-4B30-B551-DDEB4E1C5CF7Q33791976-EA71412D-5D8A-44C6-81FE-4E2CEEA37F6FQ34554961-6526BC12-6565-46C4-9962-89044E3401B2Q34795269-C74E8896-5737-4D71-8AFF-898EA58A999CQ35757818-D0E305E6-F078-4805-AB01-5BDC36FBFB5DQ35758344-C913C94B-5F1A-4455-AA1B-8B35208C0AFBQ35761727-4DA6F3E0-4AAC-4398-AA86-25969701EB70Q36259058-1EF18B9E-055B-4D0A-987F-60D10F0D1748Q38220810-DF2D203B-7FD8-4FB8-9350-1571974D4F70Q38450069-F3BE1925-2618-46B3-B61B-B7A6DF6F4514Q38537384-4C126F97-7969-4B6C-9F31-C1C20CAA3AC1Q38905308-75C00C47-F9FC-455C-84C3-F8D5ED7ABBF4Q38907478-2E9C7678-8490-470C-9407-954DB1A24CA4Q48199908-19A12D11-D6AB-451F-86BC-9656F6080CB4Q59136909-7848F401-CE1F-4FCF-B884-4CC3EE895C48
P2860
The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
The pharmacology of imepitoin: ...... for the treatment of epilepsy.
@ast
The pharmacology of imepitoin: ...... for the treatment of epilepsy.
@en
The pharmacology of imepitoin: ...... for the treatment of epilepsy.
@nl
type
label
The pharmacology of imepitoin: ...... for the treatment of epilepsy.
@ast
The pharmacology of imepitoin: ...... for the treatment of epilepsy.
@en
The pharmacology of imepitoin: ...... for the treatment of epilepsy.
@nl
prefLabel
The pharmacology of imepitoin: ...... for the treatment of epilepsy.
@ast
The pharmacology of imepitoin: ...... for the treatment of epilepsy.
@en
The pharmacology of imepitoin: ...... for the treatment of epilepsy.
@nl
P2860
P1433
P1476
The pharmacology of imepitoin: ...... for the treatment of epilepsy.
@en
P2093
Chris Rundfeldt
Wolfgang Löscher
P2860
P2888
P356
10.1007/S40263-013-0129-Z
P577
2014-01-01T00:00:00Z